ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-Stage Kidney Failure Patients

This study is ongoing, but not recruiting participants.
Study NCT00426712.   Last updated on January 22, 2008.   Information provided by Dynavax Technologies Corporation

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Hepatitis B
2 Additional conditions recognized in this trial
Hepatitis
Kidney Failure
3 More general conditions related to this trial
Digestive System Diseases
DNA Virus Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Kidney Diseases
Liver Diseases
Renal Insufficiency
Urologic Diseases
Virus Diseases
4 Interventions listed in this trial
Hepatitis B Vaccine (Recombinant)
5 Sponsors listed in this trial
Dynavax Technologies Corporation




Links to all studies - primarily for crawlers